John Reynolds

Projects

Projects per year 2014 2018 2019 2020 2024 2028

• 11 Active
• 13 Finished

Projects per year

Search results

• Finished

  An ALLG Phase 2 study to Investigate Novel Triplets to Extend Remission with Venetoclax in Elderly (INTERVENE) Acute Myeloid Leukaemia

  Reynolds, J.

  1/12/20 → 1/12/24

  Project: Research

• A randomised controlled trial of telephone-delivered psychological treatment to reduce methamphetamine use

  Lubman, D. (Primary Chief Investigator (PCI)), Manning, V. (Chief Investigator (CI)), Hall, K. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Grigg, J. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)) & Harris, A. (Chief Investigator (CI))

  1/01/20 → 31/12/23

  Project: Research

• A phase 2 study of venetoclax in combination with low-dose cytarabine in relapsing acute myeloid leukemia.

  Wei, A. (Primary Chief Investigator (PCI)), Tiong, I. S. (Chief Investigator (CI)), Reynolds, J. (Associate Investigator (AI)) & Kennedy, N. (Chief Investigator (CI))

  22/09/19 → 31/12/24

  Project: Research

• Transforming the treatment landscape in elderly Acute Myeloid Leukaemia (AML)

  Wei, A. (Primary Chief Investigator (PCI)), Bohlander, S. K. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)) & Levis, M. (Chief Investigator (CI))

  1/05/19 → 31/12/22

  Project: Research

• Novel Venetoclax Combinations To Improve Outcomes In Unfit Older Patients With Acute Myeloid Leukaemia

  Wei, A. (Primary Chief Investigator (PCI)), Reynolds, J. (Chief Investigator (CI)), Ritchie, D. S. (Chief Investigator (CI)), Ananda-Rajah, M. (Chief Investigator (CI)), Liew, D. (Associate Investigator (AI)) & Ivey, A. (Associate Investigator (AI))

  1/04/19 → 31/03/24

  Project: Research

• A registry-linked national platform trial to improve precision-based outcomes using novel therapies in acute myeloid leukaemia (AML)

  Wei, A. (Primary Chief Investigator (PCI)), Dawson, M. A. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Bohlander, S. K. (Chief Investigator (CI)), Ivey, A. (Chief Investigator (CI)), Ekert, P. (Associate Investigator (AI)), Marlton, P. (Associate Investigator (AI)) & Blombery, P. (Associate Investigator (AI))

  13/06/18 → 31/12/23

  Project: Research

• Interactive attention training technology to enhance cognitive skills in early life

  Cornish, K. (Primary Chief Investigator (PCI)), Anderson, V. (Chief Investigator (CI)), Harcourt, J. (Chief Investigator (CI)), Catroppa, C. (Chief Investigator (CI)), Kirk, H. (Chief Investigator (CI)), McIntosh, B. (Chief Investigator (CI)) & Reynolds, J. (Chief Investigator (CI))

  1/04/18 → 31/03/22

  Project: Research

• Chronic Myeloid Leukaemia: Changing the treatment paradigm

  Hughes, T. P. (Primary Chief Investigator (PCI)), Yong, A. (Chief Investigator (CI)), Branford, S. (Chief Investigator (CI)), White, D. L. (Chief Investigator (CI)), Ross, D. M. (Chief Investigator (CI)) & Reynolds, J. (Chief Investigator (CI))

  1/01/18 → 31/12/21

  Project: Research

• Analysis of circulating tumour DNA for mutational characterisation and tracking disease progression in multiple myeloma

  Spencer, A., Mithraprabhu, S., Powell, D., Reynolds, J. & Ivey, A.

  1/01/18 → 31/12/21

  Project: Research

• The International Acute Myeloid Leukaemia Platform Consortium (IAPC)

  Wei, A. (Primary Chief Investigator (PCI)), Roberts, A. W. (Chief Investigator (CI)), Dawson, M. A. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Ritchie, D. S. (Chief Investigator (CI)), Ekert, P. (Chief Investigator (CI)) & Ivey, A. (Chief Investigator (CI))

  13/04/17 → 12/04/22

  Project: Research

• The R2C Program: A randomised controlled trial of a telephone-based intervention for alcohol misuse

  Lubman, D. (Primary Chief Investigator (PCI)), Baker, A. L. (Chief Investigator (CI)), Staiger, P. K. (Chief Investigator (CI)), Best, D. (Chief Investigator (CI)), Manning, V. (Chief Investigator (CI)), Hall, K. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Harris, A. (Chief Investigator (CI)) & Grigg, J. (Project Manager)

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/17 → 31/12/20

  Project: Research

• Augmented immune targeting of a myeloma-specific tumour antigen.

  Shortt, J. (Primary Chief Investigator (PCI)), Spencer, A. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Johnstone, R. W. (Chief Investigator (CI)), Quach, H. (Chief Investigator (CI)), Grigoriadis, G. (Chief Investigator (CI)), Kalff, A. (Chief Investigator (CI)), Khong, T. (Chief Investigator (CI)), Walker, P. A. (Associate Investigator (AI)) & Powell, D. (Associate Investigator (AI))

  15/12/16 → 31/12/18

  Project: Research

• Developing and evaluating a new cost effective health and wellbeing model of care for children with a disability and their carers

  Gibbs, L. (Primary Chief Investigator (PCI)), Reddihough, D. S. (Chief Investigator (CI)), Carter, R. C. (Chief Investigator (CI)), Williams, K. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Tracy, J. (Chief Investigator (CI)) & McDonald, R. (Chief Investigator (CI))

  27/10/14 → 26/10/19

  Project: Research